China Pharma Holdings (CPHI) Net Equity Issued and Repurchased (2021)
China Pharma Holdings' (CPHI) quarterly Net Equity Issued and Repurchased came in at $7.3 million in Q4 2021, up 438.26% quarter-over-quarter from -$2.2 million in Q3 2021.
Powered by 
Analysis
China Pharma Holdings (CPHI) Net Equity Issued and Repurchased (2021) Analysis & Trends
China Pharma Holdings (CPHI) has reported Net Equity Issued and Repurchased for 1 consecutive years, with $7.3 million the latest figure, recorded in Q4 2021.
- For the quarter ending Q4 2021, Net Equity Issued and Repurchased changed N/A year-over-year to $7.3 million; the trailing twelve-month figure through Dec 2021 stood at $5.0 million (changed N/A YoY), and the FY2021 full-year result was $5.0 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased climbed to $7.3 million in Q4 2021 per CPHI's latest filing, from -$2.2 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $7.3 million in Q4 2021 and bottomed at -$2.2 million in Q3 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | - |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 141.90 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | China Pharma Holdings | 31.39 Mn | 31.08 Mn | 83,566.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 7.32 Mn |
| Sep 30, 2021 | -2.16 Mn |
| Jun 30, 2021 | -301.00 |
| Mar 31, 2021 | -154,215.00 |